Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess the tolerability and safety of OPC-14117. To evaluate effects of OPC-14117 on
cognitive function, quality of life, and activities of daily living.